Invitae to Present Data at The American Clinical Genetics Meeting 2023 That Supports Removing Barriers to Genetic Testing

– New research looking at underrepresented racial, ethnic and ancestry groups underscores the importance of universal germline genetic testing – SAN FRANCISCO, March 15, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced seven studies, including…